Skip to content
Fly High Investing
Sign In

View

Explore more with Plus or Premium

Plus and Premium add earnings and dividend charts, market-yield history and the Fly High Assistant. Premium also includes the Fly High 50 list and portfolio updates.

BME · BlackRock Health Sciences Trust

Company overview

BlackRock Health Sciences Trust invests in healthcare companies and looks for investment appreciation alongside income. Option writing stopped being a principal strategy in November 2025, so older option-driven results should not be treated as the same playbook.

Business
Healthcare equity CEF
Listing
BME · New York Stock Exchange
Reporting period
2026-06-30
Dividend schedule
Monthly

How the business works

Company dividends add income, but changes in healthcare share values and realized gains are central to this equity fund. NAV and cash paid together tell more than a bond-style income coverage number.

BME financial statements and industry allocation

Dividend & earnings snapshot

Reported earnings

Each measure shown separately, per share

Net investment income$0.07

Jan 1, 2026 to Jun 30, 2026

Distribution yield7.07%Sourced distributions divided by dated market price
Reported annual income yield0.32%Reported net investment income $0.1300 per share for 2025-01-01 to 2025-12-31, divided by approved 2025-12-31 market price $41.1300. Excludes capital gains; historical, not a current yield or forecast.
Reported annual investment income$0.13Per share for 2025 FY. Excludes investment gains.
Annual dividend$3.15Current regular payment annualized per share
Reported earnings and sources

Reported earnings for the latest four periods. Compare the same earnings measure across periods; different measures are not added together.

Reporting periodPer shareSource
Jan 1, 2026 to Jun 30, 2026$0.07SEC
Announced Sep 3, 2026

Cash distributions and reported returns

Cash distributions are the total paid per share during each reporting period, including any gains or return of capital. Period lengths may differ, so compare the dates before comparing amounts. Short periods are not annualized.

Reporting periodEnding NAVNAV changeDistributions / shareReported NAV total returnSource
Jan 1, 2026 to Jun 30, 2026$44.22+0.57%$1.57+4.48%BME SEC financial highlights. Reported cash includes all components; partial periods are not annualized.
Jan 1, 2025 to Dec 31, 2025$43.97+6.72%$3.15+15.82%BME SEC financial highlights. Reported cash includes all components; partial periods are not annualized.
Jan 1, 2024 to Dec 31, 2024$41.20-2.32%$2.61+4.09%BME SEC financial highlights. Reported cash includes all components; partial periods are not annualized.
View older history (up to 7 years)
Reporting periodEnding NAVNAV changeDistributions / shareReported NAV total returnSource
Jan 1, 2023 to Dec 31, 2023$42.18-2.59%$2.56+3.80%BME SEC financial highlights. Reported cash includes all components; partial periods are not annualized.
Jan 1, 2022 to Dec 31, 2022$43.30-9.72%$2.56-4.19%Exact BME common-share financial highlights. Annual and half-year periods do not overlap.
Jan 1, 2021 to Dec 31, 2021$47.96+5.04%$2.44+10.66%Exact BME common-share financial highlights. Annual and half-year periods do not overlap.
Jan 1, 2020 to Dec 31, 2020$45.66+10.85%$2.40+17.50%Exact BME common-share financial highlights. Annual and half-year periods do not overlap.

NAV change excludes distributions. Reported NAV total return includes reinvestment and is copied from the fund statement, not estimated by adding cash distributions to the NAV change.

How to read BME income

Dividends received after fund expenses help explain recurring income. Realized gains and return of capital are separate sources of distributions.

Watch dividend changes in the holdings and NAV over time. A high distribution rate does not guarantee stable capital.

Income and distributions

Income and cash distributions per share for the same dated periods. Shorter periods are kept separate and are not annualized. Dividends received after fund expenses help explain recurring income. Realized gains and return of capital are separate sources of distributions.

Reporting periodNet investment income/shareTotal distributions/shareIncome coverage
2026-01-01 to 2026-06-30 $0.07 $1.57 4.5%
2025-01-01 to 2025-12-31 $0.13 $3.15 4.1%
2024-01-01 to 2024-12-31 $0.07 $2.61 2.7%
View older history (up to 7 years)
Reporting periodNet investment income/shareTotal distributions/shareIncome coverage
2023-01-01 to 2023-12-31 $0.14 $2.56 5.5%
2022-01-01 to 2022-12-31 $0.11 $2.56 4.3%
2021-01-01 to 2021-12-31 $0.00 $2.44 0.0%
2020-01-01 to 2020-12-31 $0.01 $2.40 0.4%

The assets behind the earnings

How BME makes money

Financial snapshot: 2026-06-30. Research reviewed 2026-09-21. Compare results for the reporting periods shown. Historical results are not a forecast.

The assets it owns

$571.457 million net assets at June 30, 2026Five reported healthcare industry groups

Allocation excludes short-term securities and any short investments or options, following company presentation.

  • Biotechnology35%
  • Pharmaceuticals34%
  • Health care providers11.5%
  • Health care equipment10.5%
  • Life sciences tools9%

Reported industry allocation as a percent of total investments at June 30, 2026, not net assets.

BlackRock Health Sciences Trust: net assets and portfolio information, checked 2026-09-11

Reported half-year income and expenses

2026-01-01 through 2026-06-30 · $ millions

Investment income after tax items$3.807m
Net expenses$2.839m
Net investment income$0.968m

First-half 2026 net investment income was $0.07 per share, only 4.46% of distributions. That does not capture the investment gains central to BME's current equity strategy, so an income-only coverage verdict would be misleading.

BME financial statements and industry allocation

The income-producing business

Portfolio dividends and realized investment results contribute to distributions after expenses. Capital appreciation is an important objective; option writing was removed as a principal strategy on November 10, 2025.

The earnings available to shareholders depend on the cash generated by these activities after operating and financing costs. Portfolio gains, financing proceeds and recurring income should be evaluated separately.

BME financial statements and industry allocation

What the reported earnings support

BlackRock Health Sciences Trust reported $0.0700 per share for 2026-01-01 through 2026-06-30, measured as Fund net investment income per common share; actual reporting period, not annualized.

Actual per-share reporting period, without annualisation. Net investment income, realized gains, unrealized changes and cash distributions are different measures. This comparison is not the Fly High forward Dividend Coverage Ratio.

BME financial statements and industry allocation

Portfolio risk

Losses or weaker cash generation in healthcare and life-sciences investments can reduce the resources available for future distributions.

Watch for changes in the underlying exposure and the next reported results before treating the current payment as evidence of continuing earnings support.

BME financial statements and industry allocation

Distribution sustainability

A maintained payment can exceed investment results. Review NAV and reported income together rather than treating distribution yield as total return.

Watch for changes in the underlying exposure and the next reported results before treating the current payment as evidence of continuing earnings support.

BME financial statements and industry allocation

What would change the earnings picture?

Follow investment gains, NAV and distribution sources in the next report. Look for whether capital value and cash paid move together under the post-2025 strategy.

Net asset value (NAV)

NAV per share$46.28Sep 29, 2026
Market price$44.62Sep 29, 2026
PREMIUM / DISCOUNT TO NAV3.59% discountCalculated from the displayed same-date values.

NAV is the fund's assets minus liabilities, divided by shares outstanding. All values are USD per share.

CEFConnect current common-share NAV and closing market price, both dated 2026-09-29. The published premium or discount agrees with the calculation within source rounding. Older audited NAV history remains unchanged.

NAV source · Market-price source

Fly High context

Follow investment gains, NAV and distribution sources in the next report. Look for whether capital value and cash paid move together under the post-2025 strategy.

Loading current company feeds…

Dividend tax treatment

The company's 2025 estimate shows mainly capital-gain distributions and return of capital. The mix can change from year to year.

Ordinary, nonqualified
0%
Qualified dividends
3.52%
Capital-gain distributions
73.03%
Return of capital
23.46%

This 2025 estimate gives you a useful sense of where the cash may land for tax purposes. It may differ from the final forms. Think of it as a guide to the year, then use your own tax statement for the final split.

Read the source behind these figures. Your Form 1099-DIV is the guide for your own filing.

The company calls this breakdown an estimate. The company explicitly calls these amounts estimates and says they are not for tax reporting. Actual tax character depends on each shareholder's Form 1099-DIV. Never mark these rows final. Your Form 1099-DIV may show a different final mix. See the company's estimate.

Tax year: 2025.

Tax details and source
Total ordinary dividends (includes qualified)
3.52%
Section 199A portion (within ordinary dividends)
Not confirmed
Exempt-interest distributions
Not confirmed
Reporting form
Form 1099-DIV
Source date
Not stated

Qualified dividends are included in total ordinary dividends. Section 199A is a separate designation within ordinary dividends, not extra income or qualified dividend income.

Tax source

Your account type, holding period and circumstances affect treatment. Use your broker’s tax statement for filing. Return of capital generally reduces cost basis; amounts beyond basis can be taxable. IRS dividend guidance.

Public Research updated September 30, 2026 3:40 pm